| scholarly article | Q13442814 |
| P50 | author | Gennaro Ciliberto | Q38800176 |
| P2093 | author name string | R Cortese | |
| A Recchia | |||
| N La Monica | |||
| F Palombo | |||
| A Monciotti | |||
| P2860 | cites work | Site-specific integration by adeno-associated virus | Q24558738 |
| Baculovirus-mediated gene transfer into mammalian cells | Q24568382 | ||
| Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization | Q24647192 | ||
| Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome | Q24671566 | ||
| Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors | Q24683259 | ||
| Efficient gene transfer into human hepatocytes by baculovirus vectors | Q33818166 | ||
| The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity | Q34186060 | ||
| Human gene therapy | Q34419327 | ||
| Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression | Q34615481 | ||
| Adeno-associated virus vectors preferentially transduce cells in S phase. | Q35754006 | ||
| Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence | Q35829692 | ||
| Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses | Q35837026 | ||
| Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein | Q35837075 | ||
| Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit | Q35853884 | ||
| Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector | Q35872651 | ||
| Targeted integration of adeno-associated virus (AAV) into human chromosome 19 | Q35936149 | ||
| Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein | Q35943644 | ||
| Human gene therapy comes of age. | Q36220668 | ||
| Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells | Q36688082 | ||
| Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. | Q36829325 | ||
| Factors that bind to adeno-associated virus terminal repeats. | Q36829404 | ||
| Adeno-associated virus general transduction vectors: analysis of proviral structures | Q36868692 | ||
| A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication | Q36919184 | ||
| Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers | Q39873805 | ||
| Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome | Q39879196 | ||
| Role for highly regulated rep gene expression in adeno-associated virus vector production | Q39880225 | ||
| Nucleotide sequence and organization of the adeno-associated virus 2 genome | Q40143539 | ||
| The use of adenoviral vectors for gene therapy and gene transfer in vivo | Q40425311 | ||
| Baculoviruses: high-level expression in insect cells | Q40886513 | ||
| Are contemporary methods for somatic gene therapy suitable for clinical applications? | Q40894337 | ||
| Viral vectors in gene therapy | Q40945246 | ||
| Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells | Q41128137 | ||
| Gene transfer into hepatocytes and human liver tissue by baculovirus vectors | Q41157712 | ||
| Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. | Q41171031 | ||
| A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions | Q41262201 | ||
| Characterization of an adenovirus gene transfer vector containing an E4 deletion | Q41286200 | ||
| Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration | Q41431346 | ||
| Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. | Q41443981 | ||
| Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene | Q41471938 | ||
| Human immunodeficiency virus infection of cells arrested in the cell cycle | Q41531689 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| In vitro resolution of covalently joined AAV chromosome ends | Q42631247 | ||
| Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line | Q42817375 | ||
| A hybrid baculovirus-T7 RNA polymerase system for recovery of an infectious virus from cDNA. | Q45762827 | ||
| Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
| Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells | Q45841628 | ||
| Inhibition of bovine papillomavirus plasmid DNA replication by adeno-associated virus | Q45879060 | ||
| Gene therapy -- promises, problems and prospects | Q45883584 | ||
| HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. | Q55478709 | ||
| Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle | Q73254110 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 5025-5034 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector | |
| P478 | volume | 72 |
| Q39685412 | A cis-acting element that directs circular adeno-associated virus replication and packaging |
| Q34156171 | A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. |
| Q33949811 | Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat |
| Q33695816 | Adeno-associated virus vectors and hematology |
| Q27498163 | Adeno-associated virus: from defective virus to effective vector |
| Q90667012 | Baculovirus expression systems for production of recombinant proteins in insect and mammalian cells |
| Q36601836 | Baculovirus vectors for gene therapy |
| Q38442441 | Baculovirus-mediated gene delivery and RNAi applications |
| Q24790974 | Baculoviruses as Vectors for Gene Therapy against Human Prostate Cancer |
| Q39592813 | Characteristics of the adeno-associated virus preintegration site in human chromosome 19: open chromatin conformation and transcription-competent environment |
| Q33794816 | Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein |
| Q33804483 | Design and packaging of adeno-associated virus gene targeting vectors |
| Q33713396 | Development of a hybrid baculoviral vector for sustained transgene expression |
| Q33654227 | Development of animal models for adeno-associated virus site-specific integration |
| Q38951348 | Differential contribution of adeno-associated virus type 2 Rep protein expression and nucleic acid elements to inhibition of adenoviral replication in cis and in trans |
| Q24540286 | Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. |
| Q39591047 | Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases |
| Q28365551 | Gene transfer mediated by recombinant baculovirus into mouse eye |
| Q34341823 | Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19. |
| Q34341816 | Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration |
| Q39920182 | Hybrid baculovirus-adeno-associated virus vectors for prolonged transgene expression in human neural cells |
| Q33632181 | Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome |
| Q39684290 | Kinetics and frequency of adeno-associated virus site-specific integration into human chromosome 19 monitored by quantitative real-time PCR. |
| Q39741903 | Packaging of human chromosome 19-specific adeno-associated virus (AAV) integration sites in AAV virions during AAV wild-type and recombinant AAV vector production. |
| Q36098970 | Preferential integration of adeno-associated virus type 2 into a polypyrimidine/polypurine-rich region within AAVS1. |
| Q42272671 | RNA interference with special reference to combating viruses of crustacea |
| Q39594552 | Replication, integration, and packaging of plasmid DNA following cotransfection with baculovirus viral DNA. |
| Q39539705 | Selective cleavage of AAVS1 substrates by the adeno-associated virus type 2 rep68 protein is dependent on topological and sequence constraints |
| Q33825579 | Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons |
| Q35057135 | Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. |
| Q39585458 | Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination |
| Q33644983 | The Gordon Wilson Lecture. From basic virology to human gene therapy. |
| Q39698307 | The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells |
| Q34027386 | Vectors for gene therapy of cardiovascular disease |
Search more.